Alternative β-Blocker for Pregnancy Hypertension When Labetalol Unavailable
When labetalol is unavailable for a 27-week pregnant patient with uncontrolled hypertension and sinus tachycardia despite nifedipine and methyldopa, add metoprolol, pindolol, or propranolol as alternative β-blockers, with metoprolol being the most commonly used and best-tolerated option in this setting.
Guideline-Based β-Blocker Alternatives
The Hypertension Canada 2020 guidelines explicitly list acceptable alternative β-blockers for pregnancy beyond labetalol 1:
- Metoprolol (most widely used alternative)
- Pindolol
- Propranolol
- Acebutolol
These are designated as first-line oral drugs (Grade C) alongside labetalol, methyldopa, and long-acting nifedipine 1. Since your patient is already on two first-line agents (nifedipine and methyldopa) with inadequate control, adding a β-blocker from this list is the logical next step.
Why Metoprolol is Preferred
Metoprolol emerges as the best choice among the alternatives for several reasons:
- Most extensive safety data in late pregnancy 2
- Better tolerability profile than other β-blockers
- Effective for both hypertension control and sinus tachycardia management
- No association with significant fetal growth restriction when started after first trimester 2
The ESC 2011 guidelines support using metoprolol in non-severe hypertension during pregnancy 3, and multiple reviews confirm its safety and efficacy 2, 4.
Critical Contraindication: Avoid Atenolol
Do not use atenolol in this patient. Multiple guidelines and studies demonstrate that atenolol is associated with fetal growth restriction, particularly with prolonged use 3, 5, 6. The ESC 2007 guidelines specifically state "atenolol should be given with caution during pregnancy because of reports of an association with fetal growth retardation which is related to the duration of treatment" 5. Research comparing atenolol to labetalol showed significantly lower birth weights (2750g vs 3280g) and two stillbirths in the atenolol group 7.
Practical Implementation
Starting regimen for metoprolol:
- Begin with 25-50 mg twice daily
- Titrate every 2-3 days based on BP response and heart rate
- Target diastolic BP of 85 mmHg 1
- Monitor for maternal bradycardia and fetal heart rate
Alternative options if metoprolol unavailable:
- Pindolol: Has intrinsic sympathomimetic activity, may be better tolerated in patients concerned about bradycardia
- Propranolol: Non-selective β-blocker, requires more frequent dosing (TID-QID)
Monitoring Considerations
Since your patient has sinus tachycardia, the β-blocker serves dual purposes—controlling both BP and heart rate. However, monitor closely for:
- Neonatal effects: Bradycardia, hypoglycemia (though minimal risk with metoprolol) 8
- Maternal hypotension: Especially given triple therapy
- Fetal growth: Serial ultrasounds every 3-4 weeks
- Fetal heart rate patterns: NSTs as clinically indicated
When to Escalate
If BP remains ≥160/110 mmHg despite triple therapy, this constitutes a hypertensive emergency requiring hospitalization and consideration of delivery depending on maternal/fetal status 1, 9. At 27 weeks, aggressive BP control is essential to prolong pregnancy safely while preventing maternal stroke and other complications.
Second-Line Alternatives
If all β-blockers are contraindicated (e.g., severe asthma), consider second-line agents 1:
- Hydralazine (oral formulation)
- Clonidine (particularly useful if hyperemesis limits oral intake—transdermal patch available) 10
The 2020 ESC peripartum hypertension position paper notes that while labetalol is preferred, other β-blockers remain acceptable alternatives when labetalol is unavailable 11.